Search results
Found 41673 matches for
A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.
Frank Smithuis
Frank Smithuis - Professor of Tropical Medicine
Peter Ratcliffe
FRS Peter Ratcliffe - Professor of Clinical Medicine
Rose McGready
Rose McGready - Professor of Tropical Maternal and Child Health
Anita Milicic
Associate Professor Anita Milicic - Group Leader, Vaccine Formulation and Adjuvants
Peter Horby
FRS Peter Horby - Moh Family Foundation Professor of Emerging Infections and Global Health
Catherine (Sassy) Molyneux
Catherine (Sassy) Molyneux - Professor of Global Health
Peijun Zhang
Peijun Zhang - Professor of Structural Biology and WELLCOME TRUST INVESTIGATOR